IP Library › Patent Application 13880515
Patent Application
App. No. 13/880,515

THREADS OF CROSS-LINKED HYALURONIC ACID AND METHODS OF PREPARATION AND USE THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/880,515
Abstract

This disclosure relates generally to cross-linked hyaluronic acid compositions, threads made from such compositions, methods of making such threads and uses thereof, for example, in aesthetic applications (e.g., facial contouring, soft tissue augmentation products), surgery (e.g., sutures), drug delivery, negative pressure wound therapy, moist wound dressing, and the like.

Claims (31)

1 .- 9 . (canceled)

10 . A method for making a cross-linked hyaluronic acid thread, comprising:

a) combining hyaluronic acid and butanediol diglycidyl ether in an aqueous composition until the hyaluronic acid is substantially cross-linked to provide a substantially cross-linked composition, wherein the ratio of hyaluronic acid to cross-linking agent in the combining step is from about 1:2 to about 10:1;

b) extruding the substantially cross-linked composition to provide a wet thread; and

c) drying the wet thread to provide a cross-linked hyaluronic acid thread.

11 .- 15 . (canceled)

16 . The method of claim 10 , further comprising the step of dialyzing the cross-linked composition prior to extruding to provide a dialyzed substantially cross-linked composition.

17 .- 21 . (canceled)

22 . The method of claim 16 , wherein the dialyzed substantially cross-linked composition excludes components having an average molecular weight of up to about 14 kDa to about 100 kDa or up to about 200 kDa.

23 . The method of claim 10 , wherein the hyaluronic acid is present in the cross-linked composition in a concentration of about 0.1% to about 2%, or alternatively from about 0.25% to about 1.0% w/w.

26 . The method of claim 10 , further comprising the step of applying to the dry hyaluronic acid thread a sufficient amount of a therapeutic agent, a diagnostic agent, a fibrogenesis-enhancing agent, a biodegradation impeding agent, a lubricity-enhancing agent or combinations thereof, optionally followed by the step of re-drying the thread.

27 . The method of claim 10 , wherein, the step of extruding comprises extruding the wet thread onto a substrate.

28 . The method of claim 27 , wherein the substrate is selected from the group consisting of polytetrafluoroethylene (PTFE), expanded PTFE, nylon, polyethylene terephthalate (PET), polystyrene, silicon, polyurethane, and activated cellulose.

29 .- 30 . (canceled)

31 . A hyaluronic acid thread prepared by the method according to claim 10 .

32 .- 35 . (canceled)

36 . The cross-linked hyaluronic acid thread of claim 10 , further comprising the step of sterilizing the wet thread prior to drying.

37 . The cross-linked hyaluronic acid thread of claim 36 , wherein the step of sterilizing comprises e-beam sterilization.

38 - 47 . (canceled)

48 . A method of treating a wrinkle in a patient in need thereof, said method comprising;

1) inserting the thread of claim 31 into skin of the patient adjacent to or under the wrinkle; and

2) applying the thread adjacent to or under the wrinkle thereby treating the wrinkle.

49 . The method of claim 48 , wherein steps 1) and 2) are performed 2 to 6 times.

50 . A kit of parts comprising the thread of claim 31 .

51 . The kit of claim 50 , further comprising a means for delivery of the thread to a patient.

52 . The kit of claim 50 , where the means for delivery to a patient is a syringe, a needle, or an air gun.

53 .- 57 . (canceled)

58 . A method of providing facial contouring in a patient in need thereof, said method comprising:

1) inserting the thread of claim 31 into skin of the patient adjacent to or under a treatment location; and

2) applying the thread adjacent to or under the treatment location thereby providing facial contouring.

59 . The method of claim 58 , wherein the treatment location is selected from the lips, the nasolabial fold, and the tear trough.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: TAUTONA GROUP L.P.
To: ALINE AESTHETICS, LLC
Reel/Frame 032962/0781 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: ALINE AESTHETICS, LLC
To: ALLERGAN HOLDINGS FRANCE S.A.S.
Reel/Frame 032962/0910 →